Yeovil District Hospital NHS Foundation Trust runs Yeovil District Hospital in Yeovil, Somerset, England. It provides acute care for a population of about 180,000, people living in South Somerset, North and West Dorset, and parts of Mendip.

During the past decade, Yeovil District Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 3 clinical trials were completed, i.e. on average, 12% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yeovil District Hospital" #1 sponsor was "Queen Mary University of London" with 5 trials, followed by "Medical Research Council" with 4 trials sponsored, "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "University College, London" with 3 trials sponsored and "Anglo Celtic Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include 38 different institutions and companies that sponsored additional 43 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yeovil District Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Achieve Life Sciences" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Yeovil District Hospital" are "Breast Cancer" (8 trials), "Fallopian Tube Cancer" (5 trials), "Ovarian Cancer" (5 trials), "Prostate Cancer" (5 trials) and "Primary Peritoneal Cavity Cancer" (4 trials). Many other conditions were trialed in "Yeovil District Hospital" in a lesser frequency.

Most popular intervention types in "Yeovil District Hospital" are "Drug" (42 trials), "Other" (13 trials), "Procedure" (13 trials), "Biological" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "adjuvant therapy" (5 trials), "capecitabine" (5 trials), "carboplatin" (5 trials), "Placebo" (4 trials) and "quality-of-life assessment" (4 trials). Other intervention names were less common.

The vast majority of trials in "Yeovil District Hospital" are 43 trials for "All" genders, 12 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Yeovil District Hospital". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Yeovil District Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yeovil District Hospital, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".

Yeovil District Hospital has several departments that took part in Clinical trials: "Yeovil District Hospital; Macmillan Cancer Unit" - 4 trials